The BCL2 family: Regulators of the cellular life-or-death switch

Nature Reviews Cancer

Volumn 2, Issue 9, 2002, Pages 647-656

  Cory, Suzanne ^a   Adams, Jerry M ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE 9; CELL PROTEIN; CYTOCHROME C; OUTER MEMBRANE PROTEIN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; CANCER; CARCINOGENESIS; CELL DEATH; CELL SURVIVAL; CYTOTOXICITY; ENZYME ACTIVATION; GENE SWITCHING; HOMEOSTASIS; HUMAN; MITOCHONDRIAL MEMBRANE; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; NEOPLASM; PATHOLOGY; PROTEIN CONFORMATION;

ANIMALS; APOPTOSIS; CASPASES; HUMANS; MODELS, MOLECULAR; NEOPLASMS; PROTEIN CONFORMATION; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0036716281     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc883     Document Type: Review

References (154)

1. Kerr, J. F. R., Wyllie, A. H. & Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257 (1972). Cell death recognized to be an intrinsic cellular programme that plays a complementary role to mitosis in regulating tissue homeostasis.
2. Vaux, D. L., Cory, S. & Adams, J. M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-Myc to immortalize pre-B cells Nature 335, 440-442 (1988). Discovery that Bcl2 promotes cell survival. First recognition that cell survival is controlled separately from cell proliferation and that inhibition of apoptosis is a central step in tumour development. The first demonstration of cooperativity of Bcl2 and Myc in transformation.
3. Cory, S., Vaux, D. L., Strasser A., Harris, A. W. & Adams, J. M. Insights from Bcl2 and Myc: malignancy involves abrogation of apoptosis as well as sustained proliferation. Cancer Res. 59, S1685-S1692 (1999).
4. Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57-70 (2000).
5. Green, D. R. & Evan, G. I. A matter of life and death. Cancer Cell 1, 19-30 (2002).
6. Johnstone, R. W., Ruefli, A. A. & Lowe, S. W. Apoptosis: a link between cancer genetics and chemotherapy. Cell 108, 153-164 (2002).
7. Fisher, D. E. Apoptosis in cancer therapy: crossing the threshold. Cell 78, 539-542 (1994).
8. Adams, J. M. & Cory, S. The BCl-2 protein family: arbiters of cell survival. Science 281, 1322-1326 (1998).
9. Green, D. R. & Reed, J. C. Mitochondria and apoptosis. Science 281, 1309-1311 (1998).
10. Gross, A., McDonnell, J. M. & Korsmeyer, S. J. Bcl-2 family members and the mitochondria in apoptosis. Genes Dev. 13, 1899-1911 (1999).
11. Vander Heiden, M. G. & Thompson, C. B. Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? Nat. Cell Biol. 1, E209-E216 (1999).
12. Strasser, A., O'Connor, L. & Dixit, V. M. Apoptosis signaling. Annu. Rev. Biochem. 69, 217-245 (2000).
13. Adams, J. M. & Cory, S. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem. Sci. 26, 61-66 (2001).
14. Wang, X. The expanding role of mitochondria in apoptosis. Genes Dev. 15, 2922-2933 (2001).
15. Martinou, J.-C. & Green, D. R. Breaking the mitochondrial barrier. Nature Rev. Mol. Cell Biol. 2, 63-67 (2001).
16. Horvitz, H. R. Genetic control of programmed cell death in the nematode Caenorhabditis elegans. Cancer Res. 59, S1701-S1706 (1999).
17. Vaux, D. L., Weissman, I. L. & Kim, S. K. Prevention of programmed cell death in Caenorhabditis elegans by human BCL-2. Science 258, 1955-1957 (1992). This demonstration that human BCL2 could replace the worm survival gene revealed the marked evolutionary conservation of the apoptotic machinery.
18. Yuan, J., Shaham, S., Ledoux, S., Ellis, H. M. & Horvitz, H. R. The C. elegans cell death gene cell-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 75, 641-652 (1993). An illuminating moment, when developmental genetics and mammalian biochemistry converged to reveal that cell death is launched by the activation of a class of cysteine proteases, later called caspases.
19. Shi, Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell 9, 459-470 (2002).
20. Li, P. et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489 (1997). Surprising revelation that activation of an apoptosis machine in mammalian cells depends on cytochrome c, which is released from the mitochondria of cells subjected to intracellular stress.
21. Ashkenazi, A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nature Rev. Cancer 2, 420-430 (2002).
22. Oltvai, Z. N., Milliman, C. L. & Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-619 (1993). First evidence that Bcl2 has pro-apoptotic relatives.
23. Janiak, F., Leber, B. & Andrews, D. W. Assembly of Bcl-2 into microsomal and outer mitochondrial membranes. J. Biol. Chem. 269, 9842-9849 (1994).
24. L, an inhibitor of programmed cell death. Nature 381, 335-341 (1996).
25. Petros, A. M. et al. Solution structure of the antiapoptotic protein Bcl-2. Proc. Natl. Acad. Sci. USA 98, 3012-3017 (2001).
26. Huang, Q., Petros, A. M., Virgin, H. W., Fesik, S. W. & Olejniczak, E. T. Solution structure of a Bcl-2 homolog from Kaposi sarcoma virus. Proc. Natl Acad. Sci. USA 99, 3428-3433 (2002).
27. L-Bak peptide complex: recognition between regulators of apoptosis. Science 275, 983-986 (1997). Together with reference 24, this paper provided the first structural insight into how the pro- and anti-apoptotic Bcl2 family members interact.
28. Suzuki, M., Youle, R. J. & Tjandra, N. Structure of Bax: coregulation of dimer formation and intracellular localization. Cell 103, 645-654 (2000). The structure of full-length Bax unexpectedly revealed that the carboxy-terminal tail needed for membrane association occludes its surface pocket.
29. McDonnell, T. J. et al. Bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57, 79-88 (1989).
30. Strasser, A., Harris, A. W. & Cory, S. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67, 889-899 (1991).
31. Strasser, A. et al. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl Acad. Sci. USA 88, 8661-8665 (1991).
32. Sentman, C. L., Shutter, J. R., Hockenbery, D., Kanagawa, O. & Korsmeyer, S. J. Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67, 879-888 (1991).
33. Ogilvy, S. et al. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc. Natl Acad. Sci. USA 96, 14943-14948 (1999).
34. Veis, D. J., Sorenson, C. M., Shutter, J. R. & Korsmeyer, S. J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75, 229-240 (1993).
35. Motoyama, N. et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x deficient mice. Science 267, 1506-1510 (1995).
36. Print, C. G. et al. Apoptosis regulator Bcl-w is essential for spermatogenesis but appears otherwise redundant. Proc. Natl Acad. Sci. USA 95, 12424-12431 (1998).
37. Ross, A. J. et al. Testicular degeneration in Bcl-w-deficient mice. Nature Genet. 18, 251-256 (1998).
38. Hamasaki, A. et al. Accelerated neutrophil apoptosis in mice lacking A1-a, a subtype of the Bcl-2-related A1 gene. J. Exp. Med 188, 1985-1992 (1998).
39. Rinkenberger, J. L., Horning, S., Klocke, B., Roth, K. & Korsmeyer, S. J. Mcl-1 deficiency results in peri-implantation embryonic lethality. Genes Dev. 14, 23-27 (2000).
40. Huang, D. C. S. & Strasser, A. BH3-only proteins - essential initiators of apoptotic cell death. Cell 103, 839-842 (2000).
41. Conradt, B. & Horvitz, H. R. The C. elegans protein EGL-1 is required for programmed cell death and interacts with the Bcl-2-like protein CED-9. Cell 93, 519-529 (1998). Discovery that the nematode genome also encodes a BH3-only protein that interacts with the Bcl2 homologue CED-9 and is essential for developmental cell death.
42. Zong, W. X., Lindsten, T. Ross, A. J., MacGregor, G. R. & Thompson, C. B. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev. 15, 1481-1486 (2001). Demonstration that apoptosis induced by diverse cytotoxic signals requires either Bax or Bak and that they act downstream of the BH3-only proteins.
43. L sequester BH3 domain- only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell 8, 705-711 (2001).
44. Puthalakath, H., Huang, D. C. S., O'Reilly, L. A., King, S. M. & Strasser, A. The pro-apoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol. Cell 3, 287-296 (1999). Discovery that the BH3-only protein Bim is tethered to the microtubules in healthy cells and translocates to Bcl2 pro-survival proteins during apoptosis.
45. Puthalakath, H. et al. Bmf: a pro-apoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science 293, 1829-1832 (2001).
46. L. Cell 87, 619-628 (1996).
47. Li, H., Zhu, H., Xu, C.-J. & Yuan, J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491-501 (1998).
48. Luo, X., Budlhardjo, I., Zou, H., Slaughter, C. & Wang, X. Bid, a Bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94, 481-90 (1998).
49. Oda, E. et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288, 1053-1058 (2000).
50. Yu, J., Zhang, L., Hwang, P. M., Kinzler, K. W. & Vogelstein, B. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol. Cell 7, 673-682 (2001).
51. Nakano, K. & Vousden, K. H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell 7, 683-694 (2001).
52. Imaizumi, K. et al. Molecular cloning of a novel polypeptide, DP5, induced during programmed neuronal death. J. Biol. Chem. 272, 18842-18848 (1997).
53. Yin, X.-M. et al. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400, 886-891 (1999).
54. Bouillet, P. et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286, 1735-1738 (1999). Gene-knockout study reveals that the BH3-only protein Bim is a critical regulator of leukocyte homeostasis.
55. Bouillet, P. et al. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 415, 922-926 (2002).
56. Putcha, G. V. et al. Induction of Bim, a proapoptotic BH3- only Bcl-2 family member, is critical for neuronal apoptosis. Neuron 29, 615-628 (2001).
57. Bouillet, P., Cory, S., Zhang, L.-C., Strasser, A. & Adams, J. M. Degenerative disorders caused by Bcl-2 deficiency are prevented by loss of its BH3-only antagonist Bim. Dev. Cell 1, 645-653 (2001). The relative levels of BH3-only proteins and their pro-survival relatives is shown to be crucial in establishing the threshold for commitment of a cell to apoptosis and, therefore, for the control of tissue homeostasis.
58. Wang, K., Yin, X.-M., Chao, D. T., Milliman, C. L. & Korsmeyer, S. J. BID: a novel BH3 domain-only death agonist. Genes Dev. 10, 2859-2869 (1996).
59. Chou, J. J., Li, H., Salvesen, G. S., Yuan, J. & Wagner, G. Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell 96, 615-624 (1999).
60. McDonnell, J. M., Fushman, D., Milliman, C. L., Korsmeyer, S. J. & Cowburn, D. Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists. Cell 96, 625-634 (1999).
61. Zha, J., Weiler, S., Oh, K. J., Wei, M. C. & Korsmeyer, S. J. Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis. Science 290, 1761-1765 (2000).
62. Lutter, M. et al. Cardiolipin provides specificity for targeting of tBid to mitochondria. Nature Cell Biol. 2, 754-761 (2000).
63. Wei, M. C. et al. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev. 14, 2060-2071 (2000).
64. Madesh, M., Antonsson, B., Srinivasula, S. M., Alnemi, E. S. & Hajnóczky, G. Rapid kinetics of tBid-induced cytochrome c and Smac/ DIABLO release and mitochondrial depolarization. J. Biol. Chem. 277, 5651-5659 (2002).
65. Grinberg, M. et al. tBID Homooligomerizes in the mitochondrial membrane to induce apoptosis. J. Biol. Chem. 277, 12237-12245 (2002).
66. Lindsten, T. et al. The combined functions of proapoptotic Bcl-2 family members Bak and Bax are essential for normal development of multiple tissues. Mol. Cell 6, 1389-1399 (2000). Multiple developmental defects in mice lacking both Bax and Bak reveal that at least one of these proteins is required for stress-induced cell death.
67. Wei, M. C. et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292, 727-730 (2001).
68. Hsu, Y.-T. & Youle, R. J. Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations. J. Biol. Chem. 273, 10777-10783 (1998).
69. Nechushtan, A., Smith, C. L., Lamensdorf, I., Yoon, S. H. & Youle, R. J. Bax and Bak coalesce into novel mitochondria-associated clusters during apoptosis. J. Cell Biol. 153, 1265-1276 (2001).
70. Antonsson, B., Montessuit, S., Sanchez, B. & Martinou, J. C. Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J. Biol. Chem. 276, 11615-11623 (2001).
71. Mikhailov, V. et al. Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane. J. Biol. Chem. 276, 18361-18374 (2001).
72. Nechushtan, A., Smith, C. L., Hsu, Y. T. & Youle, R. J. Conformation of the Bax C-terminus regulates subcellular location and cell death. EMBO J. 18, 2330-2341 (1999).
73. Griffiths, G. J. et al. Cell damage-induced conformational changes of the pro-apoptotic protein Bak in vivo precede the onset of apoptosis. J. Cell Biol. 144, 903-914 (1999).
74. Tsujimoto, Y. & Shimizu, S. VDAC regulation by the Bcl-2 family of proteins. Cell Death Differ. 7, 1174-1181 (2000).
75. Zamzami, N. & Kroemer, G. The mitochondrion in apoptosis: how Pandora's box opens. Nature Rev. Mol. Cell Biol. 2, 67-71 (2001).
76. Antonsson, B. et al. Inhibition of Bax channel-forming activity by Bcl-2. Science 277, 370-372 (1997).
77. Antonsson, B., Montessuit, S., Lauper, S., Eskes, R. & Martinou, J. C. Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mytochondria. Biochem. J. 345, 271-278 (2000).
78. Saito, M., Korsmeyer, S. J. & Schlesinger, P. H. BAX-dependent transport of cytochrome c reconstituted in pure liposomes. Nature Cell Biol. 2, 553-555 (2000).
79. Pavlov, E. V. et al. A novel, high conductance channel of mitochondria linked to apoptosis in mammalian cells and Bax expression in yeast. J. Cell Biol. 155, 725-732 (2001).
80. O'Connor, L. et al. Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J. 17, 384-395 (1998).
81. Chen, F. et al. Translocation of C. elegans CED-4 to nuclear membranes during programmed cell death. Science 287, 1485-1489 (2000).
82. del Peso, L., González, V. M., Inohara, N., Ellis, R. E. & Núñez, G. Disruption of the CED-9/CED-4 complex by EGL-1 is a critical step for programmed cell death in C. elegans. J. Biol. Chem. 275, 27205-27211 (2000).
83. Parrish, J., Metters, H., Chen, L. & Xue, D. Demonstration of the in vivo interaction of key cell death regulators by structure-based design of second-site suppressors. Proc. Natl Acad. Sci. USA 97, 11916-11921 (2000).
84. Hengartner, M. O. & Horvitz, H. R. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene Bcl-2. Cell 76, 665-676 (1994).
85. Zou, H., Henzel, W. J., Liu, X., Lutschg, A. & Wang, X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90, 405-413 (1997).
86. L. J. Cell Biol. 149, 623-634 (2000).
87. Moriishi, K., Huang, D. C. S., Cory, S. & Adams, J. M. Bcl-2 family members do not inhibit apoptosis by binding the caspase-activator Apaf-1. Proc. Natl Acad. Sci. USA 96, 9683-9688 (1999).
88. Hu, Y., Ding, L., Spencer, D. M. & Núñez, G. WD-40 repeat region regulates Apaf-1 self-association and procaspase-9 activation. J. Biol. Chem. 273, 33489-33494 (1998).
89. Kluck, R. M., Bossy-Wetzel, E., Green, D. R. & Newmeyer, D. D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275, 1132-1136 (1997).
90. Yang, J. et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. [Au: ok?] Science 275, 1129-1132 (1997).
91. Zhivotovsky, B., Samali, A., Gahm, A. & Orrenius, S. Caspases: their intracellular localization and translocation during apoptosis. Cell Death Differ. 6, 644-651 (1999).
92. Dorstyn, L. et al. The role of cytochrome c in caspase activation in Drosophila melanogaster cells. J. Cell Biol. 156, 1089-1098 (2002).
93. Zimmermann, K. C., Ricci, J. E., Droin, N. M. & Green, D. R. The role of ARK in stress-induced apoptosis in Drosophila cells. J. Cell Biol. 156, 1077-1087 (2002).
94. Cecconi, F., Alvarez-Bolado, G., Meyer, B. I., Roth, K. A. & Gruss, P. Apaf-1 (CED-4 homologue) regulates programmed cell death in mammalian development. Cell 94, 727-737 (1998).
95. Yoshida, H. et al. Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 94, 739-750 (1998).
96. Kuida, K. et al. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 94, 325-337 (1998).
97. Hakem, R. et al. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94, 339-352 (1998).
98. Honarpour, N. et al. Embryonic neuronal death due to neurotrophin and neurotransmitter deprivation occurs independent of Apaf-1. Neuroscience 106, 263-274 (2001).
99. Honarpour, N. et al. Adult Apaf-1-deficient mice exhibit male infertility. Dev. Biol. 218, 248-258 (2000).
100. Hara, H. et al. The apoptotic protease-activating factor 1-mediated pathway of apoptosis is dispensable for negative selection of thymocytes. J. Immunol. 168, 2288-2295 (2002).
101. Haraguchi, M. et al. Apoptotic protease activating factor 1 (Apaf-1)-independent cell death suppression by Bcl-2. J. Exp. Med. 191, 1709-1720 (2000).
102. Li, K. et al. Cytochrome c deficiency causes embryonic lethality and attenuates stress-induced apoptosis. Cell 101, 389-399 (2000).
103. Bossy-Wetzel, E., Newmeyer, D. D. & Green, D. R. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J. 17, 37-49 (1998).
104. Gao, C. F. et al. Caspase-dependent cytosolic release of cytochrome c and membrane translocation of Bax in p53-induced apoptosis. Exp. Cell Res. 265, 145-151 (2001).
105. Rytömaa, M., Lehmann, K. & Downward, J. Matrix detachment induces caspase-dependent cytochrome c release from mitochondria: inhibition by PKB/Akt but not Raf signalling. Oncogene 19, 4461-4468 (2000).
106. L function and induce apoptosis through cytochrome c-independent activation of caspases. J. Biol. Chem. 214, 13298-13304 (1999).
107. Li, P.-F., Dietz, R. & von Harsdorf, R. p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J. 18, 6027-6036 (1999).
108. Von Ahsen, O., Waterhouse, N. J., Kuwana, T., Newmeyer, D. D. & Green, D. R. The 'harmless' release of cytochrome c. Cell Death Differ. 7, 1192-1199 (2000).
109. Lassus, P., Opitz-Araya, X. & Lazebnik, Y. Caspase-2 is required for stress-induced apoptosis and acts prior to mitochondrial permeabilization. Science (in the press). In certain cell lines, stress stimuli are shown to activate caspase-2 upstream of mitochondrial disruption. Together with other recent findings by Marsden et al. (see text), this work argues strongly that Bcl2 function extends beyond guarding mitochondrial integrity and is likely to involve direct regulation of the activation of several initiator caspases.
110. Lee, S. T. et al. Bcl-2 targeted to the endoplasmic reticulum can inhibit apoptosis induced by Myc but not etoposide in Rat-1 fibroblasts. Oncogene 181, 3520-3528 (1999).
111. Häcki, J. et al. Apoptotic crosstalk between the endoplasmic reticulum and mitochondria controlled by Bcl-2. Oncogene 19, 2286-2295 (2000).
112. Rudner, J. et al. Wild-type, mitochondrial and ER-restricted Bcl-2 inhibit DNA damage-induced apoptosis but do not affect death receptor-induced apoptosis. J. Cell Sci. 114, 4161-4172 (2001).
113. Rao, R. V. et al. Coupling endoplasmic reticulum stress to the cell death program: an Apaf-1-independent intrinsic pathway. J. Biol. Chem. 27, 27 (2002).
114. Nakagawa, T. et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β. Nature 403, 98-103 (2000).
115. Klic, M., Schafer, R., Hoppe, J. & Kagerhuber, U. Formation of noncanonical high molecular weight caspase-3 and -6 complexes and activation of caspase-12 during serum starvation induced apoptosis in AKR-2B mouse fibroblasts. Cell Death Differ. 9, 125-137 (2002).
116. Hannon, G. J. RNA interference, Nature 418, 244-251 (2002).
117. Los, M., Wesselborg, S. & Schulze-Osthoff, K. The role of caspases in development, immunity, and apoptotic signal transduction: lessons from knockout mice. Immunity 10, 629-639 (1999).
118. Adams, J. M. & Cory, S. Apoptosomes: engines for caspase activation. Curr. Opin. Cell Biol. (in the press).
119. Guo, Y., Srinivasula, S. M., Druilhe, A., Fernandes-Alnemri, T. & Alnemri, E. S. Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondna. J. Biol. Chem. 277, 13430-13437 (2002).
120. Nakagawa, T. & Yuan, J. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J. Cell Biol. 150, 887-894 (2000).
121. Strasser, A., Harris, A. W. & Cory, S. Eμ-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells. Oncogene 8, 1-9 (1993).
122. Strasser, A., Harris, A. W., Bath, M. L. & Cory, S. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between Myc and Bcl-2. Nature 348, 331-333 (1990). First in vivo evidence that Bcl2 is tumorigenic and can collaborate with Myc in tumour development.
123. Jager, R., Herzer, U., Schenkel, J. & Weiher, H. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-Myc-induced tumorigenesis of the mammary gland in transgenic mice. Oncogene 15, 1787-1795 (1997).
124. Naik, P., Karrim, J. & Hanahan, D. The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. Genes Dev. 10, 2105-2116 (1996).
125. Pelengaris, S., Khan, M. & I. E. G. Suppression of Myc-induced apoptosis in β cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell 109, 321-334 (2002).
126. Kogan, S. C. et al. BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor α chimeric protein (PMLRARα) to block neutrophil differentiation and initiate acute leukemia. J. Exp. Med. 193, 531-543 (2001).
127. L by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies. Genes Dev, 12, 2475-2487 (1998).
128. Rampino, N. et al. Somatic frameshift mutations in the Bax gene in colon cancers of the microsatellite mutator phenotype. Science 275, 967-969 (1997).
129. Kondo, S. et al. Mutations of the BAK gene in human gastric and colorectal cancers. Cancer Res. 60, 4328-4330 (2000).
130. Meijerink, J. P. P. et al. Hematopoetic malignancies demonstrate loss-of-function mutations of BAX. Blood 91, 2991-2997 (1998).
131. McCurrach, M. E., Connor, T. M. F., Knudson, C. M., Korsmeyer, S. J. & Lowe, S. W. Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc. Natl Acad. Sci. USA 94, 2345-2349 (1997).
132. Yin, C. Y., Knudson, C. M., Korsmeyer, S. J. & Van Dyke, T. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385, 637-640 (1997).
133. Ionov, Y., Yamamoto, H., Krajewski, S., Reed, J. C. & Perucho, M. Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution. Proc. Natl Acad. Sci. USA 97, 10872-10877 (2000).
134. Grumont, R. J., Rourke, I. J. & Gerondakis, S. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev. 13, 400-411 (1999).
135. Mayo, M. W. & Baldwin, A. S. The transcription factor NF-κB: control of oncogenesis and cancer therapy resistance. Biochim. Biophys. Acta 1470, M55-M62 (2000).
136. Sherr, C. J. The INK4a/ARF network in tumour suppression. Nature Rev. Mol. Cell Biol. 2, 731-737 (2001).
137. Strasser, A., Harris, A. W., Jacks, T. & Cory, S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 79, 329-339 (1994).
138. Schmitt, C. A., Rosenthal, C. T. & Lowe, S. W. Genetic analysis of chemoresistance in primary murine lymphomas. Nature Med. 6, 1029-1035 (2000).
139. Sartorius, U. A. & Krammer, P. H. Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines. Int. J. Cancer 97, 584-592 (2002).
140. Zhang, L., Yu, J., Park, B. H., Kinzler, K. W. & Vogelstein, B. Role of BAX in the apoptotic response to anticancer agents. Science 290, 989-992 (2000).
141. Nicholson, D. W. From bench to clinic with apoptosis-based therapeutic agents. Nature 407, 810-816 (2000).
142. Wang, J. L. et al. Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. Proc. Natl Acad. Sci. USA 97, 7124-7129 (2000).
143. L. Nature Cell Biol. 3, 173-182 (2001).
144. Tzung, S. P. et al. Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3. Nature Cell Biol. 3, 183-191 (2001).
145. Huang, Z. Bcl-2 family proteins as targets for anticancer drug design. Oncogene 19, 6627-6631 (2000).
146. Baell, J. B. & Huang, D. C. S. Prospects for targeting the Bcl-2 family of proteins to develop novel cytotoxic drugs. Biochem. Pharmacol. (in the press)
147. L or Bcl-2 Is bypassed during lymphomagenesis. Mol. Cell. Biol. 21, 5063-5070 (2001).
148. Thornberry, N. A. & Lazebnik, Y. Caspases: enemies within. Science 281, 1312-1316 (1998).
149. Rodriguez, J. & Lazebnik, Y. Caspase-9 and APAF-1 form an active holoenzyme. Genes Dev. 13, 3179-3184 (1999).
150. Acehan, D. et al. Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Mol. Cell 9, 423-432 (2002).
151. Heibein, J. A. et al. Granzyme B-mediated cytochrome c release is regulated by the Bcl-2 family members Bid and Bax. J. Exp. Med 192, 1391-1402 (2000).
152. Flores, E. R. et al. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 416, 560-564(2002).
153. Strasser, A., Harris, A. W., Huang, D. C. S., Krammer, P. H. & Cory, S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14, 6136-6147 (1995). Bcl2 was found to be unable to block apoptosis triggered by the newly discovered 'death-receptor' pathway, establishing that there are at least two distinct pathways to apoptosis in mammalian cells.
154. McDonnell, T. J. & Korsmeyer, S. J. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14:18). Nature 349, 254-256 (1991).